Leerink Partners initiated coverage on aTyr Pharma with a new price target

2/18/25 7:06:32 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Leerink Partners initiated coverage of aTyr Pharma with a rating of Outperform and set a new price target of $16.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ATYR

Date	Price Target	Rating	Analyst
2/18/2025	$16.00	Outperform	Leerink Partners
1/6/2025		Overweight	Cantor Fitzgerald
10/4/2024	$17.00	Overweight	Wells Fargo
9/5/2024	$9.00	Buy	Jefferies